FDA Approved Products

4,491 products with lifecycle intelligence, competitive pressure scores, and patent timelines.

Type:AllNDABLAANDA
Lifecycle:GrowthPeakLOE ApproachingPost-LOELaunchPre-Launch
Sort:Approval DateNameCompetitive Pressure↓
Active:Lifecycle: LOE ApproachingClear all
DIPROSONE
betamethasone dipropionate
LOE Approaching
Merck & Co.
TOPICAL · CREAM
1975
NDA
30/100
DIPROSONE
betamethasone dipropionate
LOE Approaching
Merck & Co.
TOPICAL · OINTMENT
1976
NDA
30/100
DISIPAL
orphenadrine hydrochloride
LOE Approaching
ORAL · TABLET
1957
NDA
30/100
DISOPHROL
dexbrompheniramine maleate; pseudoephedrine sulfate
LOE Approaching
Merck & Co.
ORAL · TABLET, EXTENDED RELEASE
nasal congestion due to the common coldhay fever+6
1963
NDA
30/100
DITROPAN
oxybutynin chloride
LOE Approaching
Johnson & Johnson
ORAL · TABLET
overactive bladder with symptoms of urge urinary incontinenceurgency+3
1975
NDA
30/100
DITROPAN
oxybutynin chloride
LOE Approaching
Johnson & Johnson
ORAL · SYRUP
overactive bladder with symptoms of urge urinary incontinenceurgency+3
1979
NDA
30/100
DITROPAN XL
oxybutynin chloride
LOE Approaching
Johnson & Johnson
ORAL · TABLET, EXTENDED RELEASE
overactive bladder with symptoms of urge urinary incontinenceurgency+3
1998
NDA
30/100
DIULO
metolazone
LOE Approaching
Pfizer
ORAL · TABLET
saltwater retention including: edema accompanying congestive heart failure+8
1981
NDA
30/100
DIUPRES-250
chlorothiazide; reserpine
LOE Approaching
Merck & Co.
ORAL · TABLET
pregnancyjust+3
1958
NDA
30/100
DIUPRES-500
chlorothiazide; reserpine
LOE Approaching
Merck & Co.
ORAL · TABLET
pregnancyjust+3
1958
NDA
30/100
DIURIL
chlorothiazide
LOE Approaching
ORAL · TABLET
the management of hypertension eitherto enhance the effectiveness of other antihypertensive drugs in the more severe forms of hypertension+6
1958
NDA
30/100
DIURIL
chlorothiazide
LOE Approaching
Bausch Health
ORAL · SUSPENSION
the management of hypertension eitherto enhance the effectiveness of other antihypertensive drugs in the more severe forms of hypertension+6
1961
NDA
30/100
DIVIGEL
estradiol
LOE Approaching
Convert Pharmaceuticals
TRANSDERMAL · GEL
2007
NDA
30/100
DOBUTAMINE HYDROCHLORIDE IN DEXTROSE 5%
dobutamine hydrochloride
LOE Approaching
Pfizer
INJECTION · INJECTABLE
heart failure
1993
NDA
30/100
DOBUTAMINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER
dobutamine in dextrose
LOE Approaching
Pfizer
INJECTION · INJECTABLE
heart failure
1993
NDA
30/100
DOBUTAMINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER
dobutamine hydrochloride
LOE Approaching
Baxter
INJECTION · INJECTABLE
heart failure
1993
NDA
30/100
DOBUTREX
dobutamine hydrochloride
LOE Approaching
Eli Lilly and Company
INJECTION · INJECTABLE
heart failure
1978
NDA
30/100
DOCA
desoxycorticosterone acetate
LOE Approaching
Merck & Co.
INJECTION · INJECTABLE
1939
NDA
30/100
DOCEFREZ
docetaxel
LOE Approaching
Fosun Pharma
INJECTION · INJECTABLE
metastatic breast cancer after failure of prior chemotherapymetastatic non-small cell lung cancer after failure of prior platinum-based chemotherapy+6
2011
NDA
30/100
DOCETAXEL
docetaxel
LOE Approaching
Pfizer
INJECTION · INJECTABLE
metastatic breast cancer after failure of prior chemotherapymetastatic non-small cell lung cancer after failure of prior platinum-based chemotherapy+6
2011
NDA
30/100
DOCETAXEL
docetaxel
LOE Approaching
Fosun Pharma
INJECTION · INJECTABLE
metastatic breast cancer after failure of prior chemotherapymetastatic non-small cell lung cancer after failure of prior platinum-based chemotherapy+6
2011
NDA
30/100
DOLOBID
diflunisal
LOE Approaching
Merck & Co.
ORAL · TABLET
Rheumatoid arthritis
1982
NDA
30/100
DOLOPHINE HYDROCHLORIDE
methadone hydrochloride
LOE Approaching
Hikma
ORAL · SYRUP
severepersistent pain+1
1947
NDA
30/100
DOPAMINE HYDROCHLORIDE
dopamine hydrochloride
LOE Approaching
INJECTION · INJECTABLE
1983
NDA
30/100
← PreviousPage 53 of 188Next →